Delivery Order SPE2DB22D9239-SPE2DB25FDM14
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 12 mg daily dose in 90-count quantities. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, utilizes firm fixed-price terms without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 14 mg daily dose medication (60-count supply). This firm fixed-price delivery order, issued on September 11, 2025, with an ultimate completion date of October 2, 2025, represents a tactical fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 10 mg daily dose tablets (30-count packaging). This firm fixed-price delivery order was issued on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing this work from its Park Ridge...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,353.77 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Lenvima 14 mg daily dose medication in 60-count quantities. This firm fixed-price delivery order is expected to be completed by September 23, 2025, with performance taking place at the contractor's Park Ridge facility. The award was made without a...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for LENVIMA 8 mg daily dose tablets (60-count supply) with a ceiling value of $11,353.77. This firm fixed-price delivery order, awarded on August 28, 2025, with an ultimate completion date of September 19, 2025, represents a procurement of a specialized oncology medication. The contract carries no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 8 mg daily dose tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $11,353.77, was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025. The contract contains no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,353.77 by the Defense Logistics Agency on August 28, 2025, for the supply of Lenvima 14 mg daily dose tablets in quantities of 60 units. The contract carries an ultimate completion date of September 19, 2025, and does not utilize a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,353.77 by the Defense Logistics Agency on August 22, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count). This firm fixed-price delivery order is scheduled for completion by September 15, 2025, with performance taking place at the vendor's Park Ridge location. The award was made without a set-aside designation, reflecting...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,006.95 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the supply of LENVIMA 20MG DAILY 60S, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a comprehensive range of...
- The U.S. Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. for LENVIMA 20 mg daily dose (60-count supply) valued at $11,353.77 on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was awarded without set-aside designation to the Park Ridge, Illinois-based woman-owned small business pharmaceutical wholesaler. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDM14Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 8 mg daily dose (60-count). The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent performance on Defense Logistics Agency contracts. The company's core business focuses on distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems. This specific delivery order for Lenvima, a prescription oncology medication, exemplifies the company's role in providing specialized pharmaceutical products that support the medical needs of Defense Department healthcare facilities. As a woman-owned small business registered in SAM.gov since 2001, DMS Pharmaceutical Group continues to leverage its designation to compete effectively in federal procurement markets while maintaining a robust portfolio of pharmaceutical product deliveries across multiple therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 9/23/25 |